Mario DiazNuila-Alcazar

Department of Cardiology, University Hospital Sabadell, Autonomous University of Barcelona, Barcelona, Spain and the International Society of Cardiovascular Pharmacotherapy

Expertise

Electrophysiology & Arrhythmia Atrial Fibrillation Heart Failure DOAC Advancement in Heart Failure Anticoagulation Reversal Agents Stroke Prevention in Atrial Fibrillation Prevention & Chronic Conditions

Articles by Mario DiazNuila-Alcazar

Secondary Prevention in Patients with Non Valvular Atrial Fibrillation and Previous Stroke. Is It Possible to Have an Appropriate INR Control?

Mario DiazNuila-Alcazar, Daniel Valcárcel-Paz, Marcel Santaló-Corcoy, et al

Citation: European Cardiology Review 2017;12(2):103.

DOI:

https://doi.org/10.15420/ecr.2017:23:12

Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation: Assessment, Monitoring and Treatment Reversal

Antoni Martínez-Rubio, Mario DiazNuila-Alcazar, Anna Soria Cadena, et al

Published: 22 December 2016

Citation: European Cardiology Review 2016;11(2):118–22

DOI:

https://doi.org/10.15420/ecr.2016:30:1